Kymera Therapeutics Announces Sanofi IRAK4 Collaboration Update

• click to rate

  Posted by Two Blokes Jun 25 - Filed in Stock - 2 views
  
  Sanofi to advance Kymera's next-generation oral IRAK4 degrader development candidate, KT-485, into clinical testing and will not advance KT-474